Long-term Pulmonary Outcomes After Infection With Sars-CoV-2
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sars-CoV2
- Sponsor
- University of Aarhus
- Enrollment
- 218
- Locations
- 6
- Primary Endpoint
- Six-minute walk test
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The objective of this study is to assess the long-term outcomes after hospital admission with Covid-19 with respect to pulmonary function, physical capacity, imaging, quality of life and socioeconomic outcomes.
Detailed Description
Patients will be invited to follow-up visits 3 and 12 months after hospitalization with COVID19. Inclusion will take place during 2020. We expect to enroll 180 non-ICU patients and 36 ICU patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Infection with Sars-CoV-2
Exclusion Criteria
- •Unable to attend hospital visits due to frailty or severe disease
- •Unable to understand and complete questionnaires due to intellectual or language limitations / deficits
Outcomes
Primary Outcomes
Six-minute walk test
Time Frame: Performed 12 months after discharge
Walking distance (meters) and change in oxygen saturation.
Pulmonary function tests
Time Frame: 12 months after discharge
Liter
Imaging of the lungs
Time Frame: 12 months after discharge
Expert evaluation
Secondary Outcomes
- Fatigue Assessment Score(12 months after discharge)
- Cognitive sore (MOCA)(12 months after discharge)
- Biobanking of blood(12 months after discharge)
- Blood sample at routine follow up.(12 months after discharge)
- Comorbidities(12 months after discharge)
- Short Form-36 (SF-36) questionnaire(12 months after discharge)
- Hospital anxiety and Depression score (HADS)(12 months after discharge)